Author Archives: Danielle Burgess

September 2014 Webinar – Coping with Cancer

Coping after cancer – what does this mean and how can coping help you? Whether you’ve just been diagnosed with colorectal cancer or are managing side effects after treatment, you have been impacted greatly and life has likely changed. Coping strategies can help you regain a sense of control, and learn that there is always hope for an improved quality of life. This webinar will touch on how to successfully integrate coping so you and your support team can face the road going forward. PRESENTED BY: Dr. Kristin Kilbourn, Ph.D., M.P.H Kristin is an assistant professor in the Department of Psychology at the University of Colorado Denver. She is a

Ramucirumab treatment for metastatic colorectal cancer patients

There’s news coming out of a recent clinical trial evaluating the chemotherapy drug ramucirumab (Cyramza™) and colorectal cancer patients’ response. Read more to learn about this update in treatment. Breaking research for mCRC patients Recently Eli Lilly and Company announced that the RAISE trial showed a statistically significant improvement for patients treated with ramucirumab (Cyramza™). This Phase III study was initiated in 2010 and enrolled more than 1,000 patients in 26 countries. Phase III trials compare the newest treatment with standard of care. The RAISE trial compared ramucirumab plus FOLFIRI (a combination of 5-FU and irinotecan) to FOLFIRI alone for second-line treatment of patients with metastatic colorectal cancer. The goal,

tu-marathon

Update on Lisa Fund Grant Recipient – Researcher Ho-Chou Tu

Each year our Lisa Fund awards a talented scientist with funds to research late-stage colorectal cancer. This year we awarded Dr. Ho-Chou Tu with a grant. We caught up with her to hear the latest on her research and see what motivated her to wear a Fight CRC t-shirt when she ran a half marathon last spring. Q. What’s happened since you received the research grant in April? Dr. Tu:   I have been carrying out the research project I described in the research grant. One of the challenges in colorectal cancer research is that most of the established animal models nowadays usually only develop benign tumors rather than invasive carcinoma. Sadly, it

Giving From the Heart – Or the Ice Maker

by Michael Sola  There is no doubt the ALS Ice Bucket Challenge has become a giving sensation that has brought a slew of celebrities, politicians and folks from all walks of life to the forefront of a webcam and under a cold bucket of ice water. I’d be lying if I wasn’t a little jealous of all the attention ALS is getting. There are so many worthy causes out there. When I see the nightly news programs reciting stats I can’t help but wonder, “Who’s shouting out the stats of the colon and rectal cancer community?!” Where’s the stat about how 1 in 3 Americans will be diagnosed this year?

debbie-jett-balloon

Depression and Cancer: More than a Side Effect?

This post was written by Curtis Pesmen, survivor and author of My Cancer Year. With the heightened awareness of depression this week, we hope colorectal cancer patients facing depression read this to understand the psycho-social impact of cancer and seek help if needed. On a personal note, our condolences to Curtis and his wife who had a friendship with Robin Williams and his wife. Read Curt’s tribute to him posted in Esquire this week.    For all the advances and new diagnostics in cancer therapy, a stark fact remains: There is no standard CT scan for depression. (At least not yet.) And depression often follows cancer diagnoses. This is but one reason why it remains difficult

FDA approves first non-invasive DNA test for colorectal cancer

Big news in the colorectal cancer prevention and screening community yesterday! In a never-before-seen move, the Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly proposed Cologuard as a new option for colorectal cancer screening. What is Cologuard? Cologuard, produced by Exact Sciences, is a non-invasive (not requiring insertion of instruments into the body), stool-based (you test your poo) DNA test designed to analyze the presence of blood and certain DNA mutations in a patient’s stool sample that can indicate cancer and/or precancerous polyps. Cells of DNA are released into the stool continuously as part of the digestive process. There are already at-home screening options

RecessChallenge_2014_Web_800x300

August Recess Challenge – 31 Meetings in 31 Days

Advocacy doesn’t just happen on the Hill in March. It’s something you can do from home year-round—especially during the August recess! Your members of Congress are home for the entire month of August and meeting with them is easier than you may think! Follow these steps to help us have 31 advocate meetings in 31 days and reach 100 co-sponsors of H.R. 1070 and 20 co-sponsors of S. 2348. What You Need To Get Started… Ready…  Find out who your representative and senators are here: https://www.govtrack.us/congress/members . Set… Contact your members of Congress to schedule a meeting. Members of Congress have local offices in their districts, so you won’t have to

14799131723_8a931f31ff_z

On Target for Hope – Recap from One Million Strong in Minnesota

by Danielle Burgess, Dir. of Communications Even a week after the One Million Strong event in Minnesota, I find myself getting goosebumps as the photos from my phone slowly upload to the Flickr account. Memories of children and their parents lighting up when country star and Fight CRC National Spokesman Craig Campbell walks into their hotel room to sing a few songs and offer autographs. Memories of watching our “super volunteers” Pam, Ed & Patti roll up their sleeves and make the burden of a jam-packed, two-day event seem light, and the chaos that accompanies any on-site activity seem calm. Memories of meeting new friends at Colon Cancer Coalition and seeing

PRESS RELEASE: July 16 Stakeholder Meeting with ACSCAN

Advocates Join Reps. Payne Jr., Dent, Lance Calling for Legislation to Remove Cost Barriers to Colon Cancer Screening for Seniors WASHINGTON, DC – More than 30 colon and rectal cancer advocates and survivors are on Capitol Hill today calling for members of Congress to support legislation to ensure that cost is not a barrier for Medicare beneficiaries trying to access lifesaving colon cancer screenings. They are joined by U.S. Rep. Donald Payne, Jr. (D-NJ), Rep. Charlie Dent (R-PA) and Rep. Leonard Lance (R-NJ) – champions for increased access to colon cancer screenings.   The ‘Removing Barriers to Colorectal Cancer Screening Act,’ (H.R. 1070 & S. 2348) sponsored by U.S. Rep.

Top